Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.5.3 has been added, replacing the previous v3.5.2. This appears to be a small internal update to the page rather than a change to content or features.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.5.2 has been added. Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding/operating status notice as well as the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check98 days agoChange DetectedA government funding notice banner was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.